New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
08:24 EDTTKMRTekmira Ebola drug could see emergency use in U.S., says Maxim
Maxim said the FDA's decision to change its full clinical hold on TKM-Ebola to a partial hold paves the way for potential emergency use of the drug in the U.S., if needed. Maxim noted that Tekmira's DOD contract for development of the treatment is initially worth $140M, adding that the firm expect Tekmira to receive a government supplier contract by 2018 for the drug. Maxim keeps its Buy rating and $23 price target on the stock.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
07:47 EDTTKMREMA to review BioCryst, Sarepta, Tekmira experimental Ebola medicines
Subscribe for More Information
September 25, 2014
06:41 EDTTKMRTekmira volatility flat on wide price movement
Subscribe for More Information
September 23, 2014
06:13 EDTTKMRTekmira to collaborate with international consortium researching Ebola
Subscribe for More Information
September 22, 2014
13:02 EDTTKMRTekmira surges on FDA authorization of TKM-Ebola for emergency use
Subscribe for More Information
12:57 EDTTKMRTekmira up 20% following FDA authorization of TKM-Ebola for emergency use
09:16 EDTTKMRTekmira establishes regulatory framework for emergency use of TKM-Ebola
Subscribe for More Information
September 17, 2014
15:02 EDTTKMRCongressman questions why FDA hasn't moved on Ebola drug, The Hill says
Republican Congressman Michael Burgess said he was "bewildered" as to why the FDA continues to have a hold on Tekmira's TKS-Ebloa drug, a treatment for Ebola, according to The Hill. However, Democratic Congresswoman Betty McCollum warned against using Africa as a "testing ground" for drugs that haven't been property screened, the website noted. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use